![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Autobio’s Authorization for Antibody Test Revoked
Autobio’s Authorization for Antibody Test Revoked
![Withdraws cubes](https://www.fdanews.com/ext/resources/test/Drug-Images4/Withdraw_CubeLetters.gif?t=1597093387&width=430)
The FDA has withdrawn its Emergency Use Authorization for China-based Autobio Diagnostics’ COVID-19 antibody test.
The agency said it tested the device and found that it was unlikely to be effective in identifying IgM antibodies to the SARS-COV-2 virus. IgM antibodies are usually the first produced by the immune system in response to a viral infection.
“The agency has concluded that it is unlikely that this test is effective in detecting SARS-COV-2 IgM antibodies and that the known and potential benefits of its use do not outweigh the known and potential risks,” the FDA said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct